Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease - The Conversation

1. Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease  The Conversation
2. ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long  The Washington Post
3. Daraxonrasib Drug Doubles Pancreatic Cancer Survival Rate in Phase 3 Trial  the-scientist.com
4. This Pancreatic Cancer Drug Is So Good, It Got a Standing Ovation  Bloomberg.com
5. A turning point for pancreatic cancer patients  statnews.com

from Top stories - Google News https://ift.tt/de8kfIU